• Abaloparatide

• Ametinib

• Brivarcetam

• Carfilzomib

• Dalbavancin

• Edoxaban

• Elacestrant

• Eltrombopag

• Etelcalcetide

• Exatecan

• Imeglimin

• Isavuconazonium

• Lenacapavir

• Lurbinectedin

• Relebactam

• Relugolix

• Ruxolitinib

• Selumetinib

• Setmelanotide

• Tegoprazan

• Trabectedin

• Trilaciclib

Products under patent are not offered for sales until patent expiration in the relevant country.